120 participants
A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-05-10
- Start Date:
- 2016-02-16
- Completion:
- 2018-01-31
Conditions
- Chronic Hepatitis D Infection With Hepatitis B
Interventions
- DRUG